Lupin’s subsidiary Creso Pharma ink deal hemp oil based cannaQIX

Lupin’s subsidiary and Creso Pharma ink deal for hemp oil based cannaQIX

7:55 AM, 28th August 2019
Lupin Pharma’s plant in Nagpur, India. (File photo)
Lupin Pharma’s plant in Nagpur, India. (File photo)

MUMBAI, INDIA/ SOUTH AFRICA: Pharma Dynamics, a South African subsidiary of Lupin Limited has signed a commercial agreement with Creso Pharma (Creso) for the hemp oil based cannaQIX.

The cannaQIX range of products are cannabidiol (CBD) hemp oil-based nutraceuticals, which contain full spectrum organic hemp oil extracts with CBD, vitamins and zinc, aiming to reduce stress and to support mental and nervous functions. Cannabidiol is one of many identified cannabinoids in cannabis plants and has been linked to improved anxiety, pain management, movement therapy and cognition.

The products are sugar free and contain no Tetrahydrocannabinol (THC) – the principal psychoactive constituent of cannabis.

The standardized, user-friendly strength and formulation allows precise dosage control, ensuring a reliable and stable effect over several days. The cannaQIX range has been developed per Good Manufacturing Practice standards and is produced in Switzerland by Creso’s partner, Swiss-based food and pharma development company, Domaco, Dr. med Aufdermaur AG (Domaco) to the highest Swiss quality with a “Swiss Made” label.

Creso affords Pharma Dynamics sole distribution rights of its organic, broad spectrum hemp oil nutraceutical, cannaQIX10, across South Africa, Namibia, Botswana, Zimbabwe, Swaziland, Lesotho, Angola, Mozambique and Uganda.

Pharma Dynamics hopes that the products will be available at leading retail pharmacies by year end. cannaQIX10 is available without a prescription and comes in packs of 24 lozenges.

“Creso Pharma is globally recognized as a leader in the production of cannabis products with distribution agreements already in place in various countries in Europe and Asia-Pacific. The company cultivates its cannabis at its state-of-the-art Mernova Medical facility in Windsor, Nova Scotia and its pharmaceutical leadership team ensures cutting edge science and research to develop, innovative cannabis and hemp derived products. We hope that this agreement will form the foundation of a longstanding relationship as we grow our footprint from nutraceuticals into the scheduled market as well,” said Erik Roos, CEO, Pharma Dynamics.

“The evolving regulatory situation in South Africa is providing a solid foundation on which to build this close relationship with Pharma Dynamics. “We are encouraged to see a wide range of opportunities opening up to bring premium hemp oil nutraceutical products to customers in South Africa,” added Dr Miri Halperin Wernli, Creso Pharma’s CEO and co-founder.

 © Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


BP to sell Alaska operations to Hilcorp for $5.6 billion

LONDON, UK: BP Plc has agreed to sell its entire business in Alaska to Hilcorp Alaska, based in Anchorage, Alaska. Under the terms of the agreement, H ...

Read more
Kamdhenu Paints re-opens production facility in Bhiwadi, India

PUNE, INDIA: Kamdhenu Paints has recently reopened its production facility at Chopanki Industrial Area, Bhiwadi, Rajasthan amid enthusiastic and overw ...

Read more
Ashland unveils new performance enhancing additive for waterborne architectural coatings

WILMINGTON, US: Ashland has unveiled Strodex PK-86NV specialty phosphate ester surfactant, a new performance enhancing additive for waterborne archite ...

Read more
DSM completes creation of Vitamin E JV with Nenter

HEERLEN, NETHERLANDS: Royal DSM has completed the creation of a 75/25 joint venture (JV) with Nenter & Co Inc. The JV acquired all Nenter&rsq ...

Read more
Clariant to expand maleic anhydride catalysts production in China

MUTTENZ, US: Clariant said that it will significantly expand the capacity of its catalysts production facility in Panjin, Liaoning province, Northeast ...

Read more
Nouryon plans €12 million surfactants plant expansion in Sweden

AMSTERDAM, NETHERLANDS: Nouryon said that it will double its surfactants plant capacity in Stenungsund, Sweden. This will support the growth of severa ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X